AFTER months of suspense, the Higher Education Commission has a new leader. Though the status of the HEC as a regulator of higher education affairs is reasonably well-grounded, the Commission’s future ...

WAUKEE – Chicago Cubs minor-league pitcher Tyler Ras stands to the side of the indoor baseball field at SportsPlex West on a January evening, tossing balls to high school players on the club team, the ...

Ras Kass returns with “Leopard Eats Face,” a feature-heavy Hip-Hop statement blending everything he is in one great project. AllHipHop caught up with a certified lyricist as he gears up for his latest ...

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...

Francisco Partners Ranks in Top Three of the HEC Paris-Dow Jones Annual Global Large Buyout Performance Ranking for Sixth Consecutive Year #2 ranking reflects consistent strong performance over the ...

Downers Grove, Ill.-based AllTranstek LLC has acquired the assets of Darien, Ill.-based RAS Data Services (RAS), following its identification last month as the prevailing auction bidder. AllTranstek, ...

#Pendant #Howtomake #Tutorial #LanAnhHandmade #Copperwire I make a bunny pendant, but sometimes it looks like a radish Timestamp 00:00 Preview, Materials and Tools 00:31 make a rabbit's head 03:28 ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Home equity contracts promise no payments but demand high end-term paybacks. Federal regulators warn HECs mirror risky loans from the 2008 housing crash. Rising home values and opaque terms raise long ...

HEC Compuse Enterprise has gained full control of Poyun after its Hong Kong subsidiary, Honch Electronic, acquired all issued convertible bonds of Amber Investment Partners Limited (AIP), completing ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.